Cytokinetics Inc. won US approval for a drug to treat a deadly heart condition, posing a potential threat to sales of a similar Bristol Myers Squibb Co. treatment that’s expected to be a key growth ...
SAN FRANCISCO and PORTLAND, Ore. and BOSTON, Nov. 5, 2025 /PRNewswire/ -- Drug Hunter, the leading knowledge platform for drug discovery R&D teams, today announced the appointment of Dr. Lori Friedman ...
Hosted on MSN
Merck & Co., Inc. (MRK)’s CEO Thinks He’s Got $50 Billion Of New Drugs, Says Jim Cramer
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed. Merck & Co., Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback